Bexarotene for CTCL | Therapeutic Cheat Sheet
Cutaneous T cell lymphoma (CTCL) is the most common primary cutaneous lymphoma, and in some patients, it could be persistent for decades. Therapy for CTCL depends on disease stage and response to prior treatments. In this month’s installment of Therapeutic Cheat Sheets, we will discuss use of bexarotene for the treatment of CTCL.
BEXAROTENE THERAPEUTIC CHEAT SHEET
Compiled by: Adrianna Gonzale …
Cutaneous T cell lymphoma (CTCL) is the most common primary cutaneous lymphoma, and in some patients, it could be persistent for decades. Therapy for CTCL depends on disease stage and response to prior treatments. In this month’s installment of Therapeutic Cheat Sheets, we will discuss use of bexarotene for the treatment of CTCL.
BEXAROTENE THERAPEUTIC CHEAT SHEET
Compiled by: Adrianna Gonzale … Continue reading "Bexarotene for CTCL | Therapeutic Cheat Sheet"
Women’s Health recently wrote an article about four skin conditions that are commonly misdiagnosed. Why do primary care providers sometimes misdiagnose common skin conditions? What conditions are challenging for dermatologists to diagnose? What steps can a dermatologist take to make a differential diagnosis?
For expert advice, I contacted Steve Daveluy, MD, FAAD, associate professor and pr … 
INTRODUCTION
Cutaneous side effects are relatively common in chemotherapy but vary in frequency and severity depending on the medication, dose, duration, pharmacokinetics, and pharmacodynamics. Gemcitabine, a pyrimidine nucleoside analogue, is a common oncologic agent used in the treatment of a variety of malignancies such as cancers of the head and neck, lung cancer, breast cancer, pancreatic … 
My Obsession with Cutaneous T-Cell Lymphoma (CTCL) – A Sneak Peek
In preparation for an exciting new Resident-led session at the upcoming ODAC conference, titled “My Obsession with CTCL”, I wanted to give you an overview of this broad category of diseases. I just remember my first Dermatology Grand Rounds presentation as a new resident was covering the topic of sarcoidosis. In this discussi … 